CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Dey

For profitContributed to NME

Also known as: DEY

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2002

First marketed drug

Oct 14, 1986

First NDA

Nov 18, 1999

Last known activity

Mar 1, 2012

Acquired by Mylan on Jun 1, 2007

Timeline

1970s

  1. Jul 1, 1977

    Dey— Founded

1980s

  1. Oct 14, 1986

    acetylcysteine— Marketing Organization

1990s

  1. Nov 18, 1999

    poractant alfa— NDA Organization

2000s

  1. Jun 1, 2007

    Mylan— Acquired By

Drugs by trial phase (7 distinct, 21 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (5)

Recent trials (22)

Details

Founded
Napa, CA, US Jul 1, 1977
First NDA
Nov 18, 1999
Last known activity
Mar 1, 2012

Designations held

  • Orphan drug

Notes

Acquired by Mylan